Biosante Pharmaceuticals Inc (NASDAQ:BPAX)
CAPS Rating:
A biopharmaceutical company that licenses and develops hormone therapy products to treat men and women.
Growing the love for investing
A biopharmaceutical company that licenses and develops hormone therapy products to treat men and women.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
i got in at .67 and am happy I did. I am hoping for good news on feb. 14th. Trying to decide if I should sell before then?!
NEW YORK, Feb. 9, 2012 -- /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential securities fraud at BioSante Pharmaceuticals, Inc. ("BioSante" or the "Company") (Nasdaq: BPAX).